China vs Uruguay: The number of people with susceptibility test result for rifampicin
China
79.92
in 2021
Uruguay
80.19
in 2021
China rank
95th
Uruguay rank
93rd
The number of people with susceptibility test result for rifampicin over time
- China
- Uruguay
How they compare
Uruguay currently reports 80.19 against 79.92 in China, a difference of 0.27.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Uruguay ahead.
China ranks 95th and Uruguay ranks 93rd of 146 countries.
Across the 2 decades both report, China averaged higher in 1 and Uruguay in 1.
Head to head by decade
| Decade | China | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.88 | 83.76 | 23.88 | Uruguay |
| 2020s | 81.69 | 80.16 | 1.53 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, China or Uruguay?
- Uruguay, at 80.19 against 79.92 in China as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between China and Uruguay?
- 0.27, with Uruguay ahead.
- How many years of comparable data are there for China and Uruguay?
- 5 years are reported by both, from 2017 to 2021.
- How do China and Uruguay rank globally for the number of people with susceptibility test result for rifampicin?
- China ranks 95th and Uruguay ranks 93rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.